Oral Vaccination Against Helicobacter pyloriInfection Is Not Effective in Mice With Fas Ligand Deficiency
暂无分享,去创建一个
[1] S. Czinn,et al. Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4 , 2003, Infection and Immunity.
[2] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[3] A. Hamad,et al. B220+ Double-Negative T Cells Suppress Polyclonal T Cell Activation by a Fas-Independent Mechanism That Involves Inhibition of IL-2 Production , 2003, The Journal of Immunology.
[4] S. Krakowka,et al. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. , 1992, Gastroenterology.
[5] H. Wajant,et al. The Fas Signaling Pathway: More Than a Paradigm , 2002, Science.
[6] J. Kusters. Recent Developments in Helicobacter pylori Vaccination , 2001, Scandinavian journal of gastroenterology. Supplement.
[7] T. Giese,et al. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. , 1995, Journal of immunology.
[8] E. Brooks,et al. Negative Selection of T Cells by Helicobacter pylori as a Model for Bacterial Strain Selection by Immune Evasion1 , 2001, The Journal of Immunology.
[9] Y. Koga,et al. Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer , 1999, Gut.
[10] M F Dixon,et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.
[11] N. Jones,et al. Helicobacter pylori Induces Gastric Epithelial Cell Apoptosis in Association with Increased Fas Receptor Expression , 1999, Infection and Immunity.
[12] N. Jones,et al. Fascination with bacteria-triggered cell death: the significance of Fas-mediated apoptosis during bacterial infection in vivo. , 2003, Microbes and infection.
[13] H. Yeger,et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. , 1997, The American journal of pathology.
[14] A. A. Akhiani,et al. Vaccine-Induced Immunity against Helicobacter pylori Infection Is Impaired in IL-18-Deficient Mice1 , 2004, The Journal of Immunology.
[15] K. Goh. Update on the management of Helicobacter pylori infection, including drug‐resistant organisms , 2002, Journal of gastroenterology and hepatology.
[16] R. Rappuoli,et al. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? , 2003, Microbes and infection.
[17] S. Czinn,et al. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. , 1997, Gastroenterology.
[18] E. Furth,et al. Altered gastric epithelial cell kinetics in Helicobacter pylori‐associated intestinal metaplasia: Implications for gastric carcinogenesis , 2000, International journal of cancer.
[19] A. A. Akhiani,et al. Protection Against Helicobacter pylori Infection Following Immunization Is IL-12-Dependent and Mediated by Th1 Cells1 , 2002, The Journal of Immunology.
[20] B. Wren,et al. Helicobacter pylori vaccine strategies--triggering a gut reaction. , 2000, Immunology today.
[21] R. Korah,et al. In vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. , 2000, The Journal of infectious diseases.
[22] S. Moss,et al. Helicobacter pylori induced apoptosis , 1998, Gut.
[23] S. Nagata,et al. Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.
[24] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[25] Li Zhang,et al. The Immune Regulatory Function of Lymphoproliferative Double Negative T Cells In Vitro and In Vivo , 2002, The Journal of experimental medicine.
[26] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[27] T. Kosaka,et al. Post-immunisation gastritis and Helicobacterinfection in the mouse: a long term study , 2001, Gut.
[28] T. Giese,et al. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. , 1994, Journal of immunology.
[29] P. Krammer,et al. The CD95 system and the death of a lymphocyte. , 1997, Seminars in immunology.
[30] S. Suerbaum,et al. Helicobacter pylori infection , 2013, Nature Reviews Disease Primers.
[31] S. Czinn,et al. Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice , 2002, Infection and Immunity.
[32] J. Holmgren,et al. Effects of Oral Vaccination and Immunomodulation by Cholera Toxin on Experimental Helicobacter pylori Infection, Reinfection, and Gastritis , 2002, Infection and Immunity.
[33] A. Blum,et al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. , 1998, Gastroenterology.
[34] P. Shannon,et al. Enhanced Disease Severity in Helicobacter pylori-Infected Mice Deficient in Fas Signaling , 2002, Infection and Immunity.
[35] T. Giese,et al. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells. , 1995, International immunology.